(Q52072398)

English

Prolactin response to sodium valproate in schizophrenics with and without tardive dyskinesia.

scientific article published in January 1988

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 April 2018

http://europepmc.org/abstract/MED/3148149

Prolactin response to sodium valproate in schizophrenics with and without tardive dyskinesia. (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 April 2018

http://europepmc.org/abstract/MED/3148149

0 references

1 reference

based on heuristic

6

1 reference

Europe PubMed Central

PubMed publication ID

21 April 2018

http://europepmc.org/abstract/MED/3148149

author name string

P Monteleone

1

1 reference

Europe PubMed Central

PubMed publication ID

21 April 2018

http://europepmc.org/abstract/MED/3148149

M Maj

2

1 reference

Europe PubMed Central

PubMed publication ID

21 April 2018

http://europepmc.org/abstract/MED/3148149

M G Ariano

3

1 reference

Europe PubMed Central

PubMed publication ID

21 April 2018

http://europepmc.org/abstract/MED/3148149

M Iovino

4

1 reference

Europe PubMed Central

PubMed publication ID

21 April 2018

http://europepmc.org/abstract/MED/3148149

L Fiorenza

5

1 reference

Europe PubMed Central

PubMed publication ID

21 April 2018

http://europepmc.org/abstract/MED/3148149

publication date

1 January 1988

1 reference

Europe PubMed Central

PubMed publication ID

21 April 2018

http://europepmc.org/abstract/MED/3148149

Psychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

21 April 2018

http://europepmc.org/abstract/MED/3148149

96

1 reference

Europe PubMed Central

PubMed publication ID

21 April 2018

http://europepmc.org/abstract/MED/3148149

2

1 reference

Europe PubMed Central

PubMed publication ID

21 April 2018

http://europepmc.org/abstract/MED/3148149

223-226

1 reference

Europe PubMed Central

PubMed publication ID

21 April 2018

http://europepmc.org/abstract/MED/3148149

https://scigraph.springernature.com/pub.10.1007/bf00177564

0 references

Research diagnostic criteria: rationale and reliability

1 reference

https://pubmed.ncbi.nlm.nih.gov/3148149

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association with persistent neuroleptic-induced dyskinesia of regional changes in brain GABA synthesis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3148149

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Abnormal involuntary movements in schizophrenia: are they related to the disease process or its treatment? Are they associated with changes in dopamine receptors?

1 reference

https://pubmed.ncbi.nlm.nih.gov/3148149

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Growth Hormone Responses to Apomorphine HCl in Schizophrenic Patients on Drug Holidays and at Relapse

1 reference

https://pubmed.ncbi.nlm.nih.gov/3148149

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pharmacology of tardive dyskinesias

1 reference

https://pubmed.ncbi.nlm.nih.gov/3148149

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Interaction Between GABA and Dopamine: Implications for Schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/3148149

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

GABAergic supersensitivity within the pars reticulata of the rat substantia nigra following chronic haloperidol administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/3148149

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dynamic utilization of GABA in substantia nigra: regulation by dopamine and GABA in the striatum, and its clinical and behavioral implications

1 reference

https://pubmed.ncbi.nlm.nih.gov/3148149

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Failure of the GABAergic drug, sodium valproate, to reduce basal plasma prolactin secretion in chronic schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/3148149

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Brain gamma-aminobutyric acid abnormality in tardive dyskinesia. Reduction in cerebrospinal fluid GABA levels and therapeutic response to GABA agonist treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/3148149

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

GABAergic control of anterior pituitary hormone secretion

1 reference

https://pubmed.ncbi.nlm.nih.gov/3148149

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Classical and non-classical neuroleptics induce supersensitivity of nigral GABA-ergic mechanisms in the rat

1 reference

https://pubmed.ncbi.nlm.nih.gov/3148149

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00177564

1 reference

Europe PubMed Central

PubMed publication ID

21 April 2018

http://europepmc.org/abstract/MED/3148149

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 April 2018

http://europepmc.org/abstract/MED/3148149

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52072398&oldid=1381471532"